Cumberland Pharmaceuticals
CPIX
48 hedge funds and large institutions have $23.2M invested in Cumberland Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
2% more funds holding
Funds holding: 47 → 48 (+1)
14% less capital invested
Capital invested by funds: $27M → $23.2M (-$3.78M)
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$2.67M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$715K |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
+$368K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$77.1K |
| 5 |
CCM
Coldstream Capital Management
Bellevue,
Washington
|
+$74.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.23M |
| 2 |
SLG
Stanley-Laman Group
Berwyn,
Pennsylvania
|
-$216K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$155K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$94K |
| 5 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$78.4K |
CPIX Hedge Fund Activity: Q1 2016 in Review
48 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q1 2016, worth a combined $23.2M — down 14% from $27M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CPIX positions and 1 closed out — a net gain of 1 holder — while 12 added to existing stakes and 15 trimmed.
The largest buyer was Ariel Investments, adding an estimated $2.67M. The largest seller was Millennium Management, exiting entirely with an estimated $3.23M sold.
- 48 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q1 2016, up from 47 in Q4 2015.
- Funds reported $23.2M of Cumberland Pharmaceuticals stock for Q1 2016, down 14% quarter-over-quarter.
- 2 funds opened new Cumberland Pharmaceuticals positions in Q1 2016 and 1 closed out, a net change of +1 holder.
- The largest Cumberland Pharmaceuticals buyer in Q1 2016 was Ariel Investments, an estimated $2.67M added.
- The largest Cumberland Pharmaceuticals seller in Q1 2016 was Millennium Management, an estimated $3.23M sold.
Based on aggregated 13F filings for Q1 2016.